Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia
- Author
- FREUND, M; HILD, F; HIDDEMANN, W; HINRICHS, F; BALLEISEN, L; FONATSCH, C; POLIWODA, H; GROTE-METKE, A; NOWAK, R; OTREMBA, B; WÖRMANN, B; KOCH, O; DOHMEN, M; KLEINE, H.-D; LINK, H
Medizinische Hochschule Hannover, Abt. Hämatologie Onkologie, W-30623 Hannover, Germany - Conference title
- Interferon in the treatment of chronic myeloid leukemia. Workshop
- Conference name
- Interferon in the treatment of chronic myeloid leukemia. Workshop (Flims 1993-02-04)
- Source
Seminars in hematology. 1993, Vol 30, Num 3, pp 11-13 ; SUP3 ; ref : 11 ref
- CODEN
- SEHEA3
- ISSN
- 0037-1963
- Scientific domain
- Hematology
- Publisher
- Elsevier, New York, NY
- Publication country
- United States
- Document type
- Conference Paper
- Language
- English
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R04 Combined treatments (chemotherapy of immunotherapy associated with an other treatment)
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 4911269
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:99:\"Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Seminars in hematology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Semin. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"1993\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:2:\"11\";s:8:\"\u0000*\u0000epage\";s:2:\"13\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0037-1963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"FREUND\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:7:\"HILD, F\";i:1;s:12:\"HIDDEMANN, W\";i:2;s:11:\"HINRICHS, F\";i:3;s:12:\"BALLEISEN, L\";i:4;s:11:\"FONATSCH, C\";i:5;s:11:\"POLIWODA, H\";i:6;s:14:\"GROTE-METKE, A\";i:7;s:8:\"NOWAK, R\";i:8;s:10:\"OTREMBA, B\";i:9;s:11:\"W\u00d6RMANN, B\";i:10;s:7:\"KOCH, O\";i:11;s:9:\"DOHMEN, M\";i:12;s:12:\"KLEINE, H.-D\";i:13;s:7:\"LINK, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"SEHEA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP3\";s:9:\"\u0000*\u0000btitle\";s:65:\"Interferon in the treatment of chronic myeloid leukemia. Workshop\";s:8:\"\u0000*\u0000title\";s:99:\"Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:99:\"Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Seminars in hematology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Semin. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"1993\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:2:\"11\";s:8:\"\u0000*\u0000epage\";s:2:\"13\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0037-1963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"FREUND\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:7:\"HILD, F\";i:1;s:12:\"HIDDEMANN, W\";i:2;s:11:\"HINRICHS, F\";i:3;s:12:\"BALLEISEN, L\";i:4;s:11:\"FONATSCH, C\";i:5;s:11:\"POLIWODA, H\";i:6;s:14:\"GROTE-METKE, A\";i:7;s:8:\"NOWAK, R\";i:8;s:10:\"OTREMBA, B\";i:9;s:11:\"W\u00d6RMANN, B\";i:10;s:7:\"KOCH, O\";i:11;s:9:\"DOHMEN, M\";i:12;s:12:\"KLEINE, H.-D\";i:13;s:7:\"LINK, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"SEHEA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP3\";s:9:\"\u0000*\u0000btitle\";s:65:\"Interferon in the treatment of chronic myeloid leukemia. Workshop\";s:8:\"\u0000*\u0000title\";s:99:\"Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:99:\"Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Seminars in hematology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Semin. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"1993\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:2:\"11\";s:8:\"\u0000*\u0000epage\";s:2:\"13\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0037-1963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"FREUND\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:7:\"HILD, F\";i:1;s:12:\"HIDDEMANN, W\";i:2;s:11:\"HINRICHS, F\";i:3;s:12:\"BALLEISEN, L\";i:4;s:11:\"FONATSCH, C\";i:5;s:11:\"POLIWODA, H\";i:6;s:14:\"GROTE-METKE, A\";i:7;s:8:\"NOWAK, R\";i:8;s:10:\"OTREMBA, B\";i:9;s:11:\"W\u00d6RMANN, B\";i:10;s:7:\"KOCH, O\";i:11;s:9:\"DOHMEN, M\";i:12;s:12:\"KLEINE, H.-D\";i:13;s:7:\"LINK, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"SEHEA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP3\";s:9:\"\u0000*\u0000btitle\";s:65:\"Interferon in the treatment of chronic myeloid leukemia. Workshop\";s:8:\"\u0000*\u0000title\";s:99:\"Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:99:\"Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Seminars in hematology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Semin. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"1993\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:2:\"11\";s:8:\"\u0000*\u0000epage\";s:2:\"13\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0037-1963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"FREUND\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:7:\"HILD, F\";i:1;s:12:\"HIDDEMANN, W\";i:2;s:11:\"HINRICHS, F\";i:3;s:12:\"BALLEISEN, L\";i:4;s:11:\"FONATSCH, C\";i:5;s:11:\"POLIWODA, H\";i:6;s:14:\"GROTE-METKE, A\";i:7;s:8:\"NOWAK, R\";i:8;s:10:\"OTREMBA, B\";i:9;s:11:\"W\u00d6RMANN, B\";i:10;s:7:\"KOCH, O\";i:11;s:9:\"DOHMEN, M\";i:12;s:12:\"KLEINE, H.-D\";i:13;s:7:\"LINK, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"SEHEA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP3\";s:9:\"\u0000*\u0000btitle\";s:65:\"Interferon in the treatment of chronic myeloid leukemia. Workshop\";s:8:\"\u0000*\u0000title\";s:99:\"Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:99:\"Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Seminars in hematology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Semin. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"1993\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:2:\"11\";s:8:\"\u0000*\u0000epage\";s:2:\"13\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0037-1963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"FREUND\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:7:\"HILD, F\";i:1;s:12:\"HIDDEMANN, W\";i:2;s:11:\"HINRICHS, F\";i:3;s:12:\"BALLEISEN, L\";i:4;s:11:\"FONATSCH, C\";i:5;s:11:\"POLIWODA, H\";i:6;s:14:\"GROTE-METKE, A\";i:7;s:8:\"NOWAK, R\";i:8;s:10:\"OTREMBA, B\";i:9;s:11:\"W\u00d6RMANN, B\";i:10;s:7:\"KOCH, O\";i:11;s:9:\"DOHMEN, M\";i:12;s:12:\"KLEINE, H.-D\";i:13;s:7:\"LINK, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"SEHEA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP3\";s:9:\"\u0000*\u0000btitle\";s:65:\"Interferon in the treatment of chronic myeloid leukemia. Workshop\";s:8:\"\u0000*\u0000title\";s:99:\"Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
